Cargando…
Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10–30% of the cases. The studies were mainly focused...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848193/ https://www.ncbi.nlm.nih.gov/pubmed/31712709 http://dx.doi.org/10.1038/s41598-019-52911-1 |
_version_ | 1783469043589578752 |
---|---|
author | Zaklyazminskaya, Elena Mikhailov, Vadim Bukaeva, Anna Kotlukova, Natalia Povolotskaya, Inna Kaimonov, Vladimir Dombrovskaya, Anna Dzemeshkevich, Sergey |
author_facet | Zaklyazminskaya, Elena Mikhailov, Vadim Bukaeva, Anna Kotlukova, Natalia Povolotskaya, Inna Kaimonov, Vladimir Dombrovskaya, Anna Dzemeshkevich, Sergey |
author_sort | Zaklyazminskaya, Elena |
collection | PubMed |
description | Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10–30% of the cases. The studies were mainly focused on the adult or mixed age group of patients with DCM. The mutation rate in the TTN gene, the characteristics of manifestations and their prognostic significance in childhood have not been studied. To determine TTN mutation rate in children with DCM and the relevance of including this gene in the DNA diagnostic protocol for paediatric DCM, complete clinical and instrumental examination of 36 DCM patients (up to 18 years) with the manifestation of the disease was conducted in specialised cardiology centres. Molecular genetic testing included sequencing of coding and adjacent regulatory regions of the major cardiac TTN isoform N2BA using IonTorrent ™ semiconductor sequencing (for 25 isolated cases) and trio whole exome sequencing (trio WES)on the Illumina platform (for 11 family cases). Our pilot group included 36 probands with DCM diagnosis first established on the basis of the generally accepted criteria at the age of 5 days to 18 years(average age: 6.5 years). The sex ratio (M:F) was 23: 8. There were 25 sporadic DCM cases and 11 cases of familial DCM (at least one of the parents and/or siblings were also diagnosed with DCM). The only likely pathogenic truncating variant p.Arg33703*in the TTN gene (TTNtv) was found in a 16-year-oldmale proband out of 36 (3%). Apparently, TTN-dependent forms of DCMs manifest later at a young (but older than 18 years) or more mature age, and TTN gene cannot be considered as the first-line genetic testing for DCM in the paediatric group, despite several studies have reported a generally high mutation rate in this gene with DCM. Further research is needed to compare the representation of mutations in the TTN gene in different age groups of DCM patients. |
format | Online Article Text |
id | pubmed-6848193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68481932019-11-19 Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study Zaklyazminskaya, Elena Mikhailov, Vadim Bukaeva, Anna Kotlukova, Natalia Povolotskaya, Inna Kaimonov, Vladimir Dombrovskaya, Anna Dzemeshkevich, Sergey Sci Rep Article Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10–30% of the cases. The studies were mainly focused on the adult or mixed age group of patients with DCM. The mutation rate in the TTN gene, the characteristics of manifestations and their prognostic significance in childhood have not been studied. To determine TTN mutation rate in children with DCM and the relevance of including this gene in the DNA diagnostic protocol for paediatric DCM, complete clinical and instrumental examination of 36 DCM patients (up to 18 years) with the manifestation of the disease was conducted in specialised cardiology centres. Molecular genetic testing included sequencing of coding and adjacent regulatory regions of the major cardiac TTN isoform N2BA using IonTorrent ™ semiconductor sequencing (for 25 isolated cases) and trio whole exome sequencing (trio WES)on the Illumina platform (for 11 family cases). Our pilot group included 36 probands with DCM diagnosis first established on the basis of the generally accepted criteria at the age of 5 days to 18 years(average age: 6.5 years). The sex ratio (M:F) was 23: 8. There were 25 sporadic DCM cases and 11 cases of familial DCM (at least one of the parents and/or siblings were also diagnosed with DCM). The only likely pathogenic truncating variant p.Arg33703*in the TTN gene (TTNtv) was found in a 16-year-oldmale proband out of 36 (3%). Apparently, TTN-dependent forms of DCMs manifest later at a young (but older than 18 years) or more mature age, and TTN gene cannot be considered as the first-line genetic testing for DCM in the paediatric group, despite several studies have reported a generally high mutation rate in this gene with DCM. Further research is needed to compare the representation of mutations in the TTN gene in different age groups of DCM patients. Nature Publishing Group UK 2019-11-11 /pmc/articles/PMC6848193/ /pubmed/31712709 http://dx.doi.org/10.1038/s41598-019-52911-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zaklyazminskaya, Elena Mikhailov, Vadim Bukaeva, Anna Kotlukova, Natalia Povolotskaya, Inna Kaimonov, Vladimir Dombrovskaya, Anna Dzemeshkevich, Sergey Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study |
title | Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study |
title_full | Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study |
title_fullStr | Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study |
title_full_unstemmed | Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study |
title_short | Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study |
title_sort | low mutation rate in the ttn gene in paediatric patients with dilated cardiomyopathy – a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848193/ https://www.ncbi.nlm.nih.gov/pubmed/31712709 http://dx.doi.org/10.1038/s41598-019-52911-1 |
work_keys_str_mv | AT zaklyazminskayaelena lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT mikhailovvadim lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT bukaevaanna lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT kotlukovanatalia lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT povolotskayainna lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT kaimonovvladimir lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT dombrovskayaanna lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy AT dzemeshkevichsergey lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy |